首页> 美国卫生研究院文献>Acta Veterinaria Scandinavica >Environmental resistance development to influenza antivirals: a case exemplifying the need for a multidisciplinary One Health approach including physicians
【2h】

Environmental resistance development to influenza antivirals: a case exemplifying the need for a multidisciplinary One Health approach including physicians

机译:对流感抗病毒药的环境抗药性发展:这是一个案例表明需要包括医生在内的多学科One Health方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A multidisciplinary approach is a prerequisite for One Health. Physicians are important players in the One Health team, yet they are often hard to convince of the benefits of the One Health approach. Here, the case for multidisciplinarity including physicians is made using the example of environmental resistance development to influenza antivirals. Neuraminidase inhibitors are the major class of anti-influenza pharmaceuticals, and extensively stockpiled globally as a cornerstone of pandemic preparedness, especially important in the first phase before vaccines can be mass-produced. The active metabolite of oseltamivir that is excreted from treated patients degrades poorly in conventional sewage treatment processes and has been found in river waters. Dabbling ducks constitute the natural influenza A virus reservoir and often reside near sewage treatment plant outlets, where they may be exposed to neuraminidase inhibitor residues. In vivo experiments using influenza-infected Mallards exposed to neuraminidase inhibitors present in their water have shown resistance development and persistence, demonstrating that resistance may be induced and become established in the influenza strains circulating in natural hosts. Neuraminidase inhibitor resistance genes may become part of a human-adapted influenza virus with pandemic potential through reassortment or direct transmission. A pandemic caused by a neuraminidase inhibitor-resistant influenza virus is a serious threat as the first line defense in pandemic preparedness would be disarmed. To assess the risk for environmental influenza resistance development, a broad multidisciplinary team containing chemists, social scientists, veterinarians, biologists, ecologists, virologists, epidemiologists, and physicians is needed. Information about One Health early in high school and undergraduate training, an active participation of One Health-engaged physicians in the debate, and more One Health-adapted funding and publication possibilities are suggested to increase the possibility to engage physicians.
机译:多学科方法是“一个健康”计划的前提。内科医生是“一心一意”团队的重要参与者,但他们通常很难相信“一心一意”方法的好处。在此,以对流感抗病毒药的环境抵抗力发展为例,提出了包括医生在内的多学科案例。神经氨酸酶抑制剂是抗流感药物的主要类别,并且在全球范围内大量储存,作为大流行防范的基石,在大规模生产疫苗之前的第一阶段尤为重要。从接受治疗的患者中排出的奥司他韦的活性代谢产物在常规污水处理过程中降解较差,并且已在河水中发现。涉水鸭构成天然的甲型流感病毒库,通常居住在污水处理厂附近,在那里它们可能暴露于神经氨酸酶抑制剂残留物。使用暴露在水中的神经氨酸酶抑制剂暴露于流感病毒感染的野鸭的体内实验显示出耐药性的发展和持久性,表明在自然宿主中传播的流感病毒株中可能诱导并建立了耐药性。神经氨酸酶抑制剂抗性基因可能通过重组或直接传播而成为具有大流行潜力的人类适应性流感病毒的一部分。由耐神经氨酸酶抑制剂的流感病毒引起的大流行是严重威胁,因为大流行防范的一线防御将被解除。为了评估环境抗药性发展的风险,需要一个由化学家,社会科学家,兽医,生物学家,生态学家,病毒学家,流行病学家和医师组成的广泛的跨学科团队。建议增加有关One Health的信息,这些信息在高中和大学期间曾接受过早期培训,One Health参与的医生积极参与辩论以及更多采用One Health的资金和出版可能性,这些都增加了与医生接触的可能性。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号